10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of September 8, 2026, TXG trades at $62.43 with a market cap of $8.16B and a P/E ratio of -106.19. TXG moved +0.00% today. Year to date, TXG is +284.12%; over the trailing twelve months it is +348.78%. Its 52-week range spans $6.78 to $66.94. Analyst consensus is buy with an average price target of $52.00. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
14 analysts cover TXG: 0 strong buy, 6 buy, 8 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $52.00.
| Metric | Value |
|---|---|
| Price | $62.43 |
| Market Cap | $8.16B |
| P/E Ratio | -106.19 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.94 |
| 52-Week Low | $6.78 |
| Volume | 4.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $616.91M |
| Net Income | $-75.13M |
| Gross Margin | 70.03% |
14 analysts cover TXG: 0 strong buy, 6 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $52.00.